Sadelain was elected for pioneering scientific studies that laid the groundwork for chimeric antigen receptor T cell (CAR-T) immunotherapy for cancer and for advancing its clinical application.
The study presents the first high-resolution 3D structure of an important protein of the malaria parasite, opening new avenues for anti-malarial drug development.
Drugs already in development may have the potential to block the chemical and help people exposed to trauma in childhood, who do not often respond to SSRIs.
Sadelain, a pioneer of cell therapies that have transformed the treatment of blood cancers, has set his sights on creating cell therapies for more cancers, autoimmune diseases, and other diseases.
Uma M. Reddy, professor of obstetrics and gynecology, is among a select group of leaders in medicine and health elected to the National Academy of Medicine in 2024.
About 15 years ago, Farber created the first tissue bank dedicated to studying the human immune system to paint a more complete picture of the immune system and how it ages. The tissue bank draws on ...
Legend has it that Marie Antoinette’s hair turned gray overnight just before her beheading in 1791. Though the legend is inaccurate—hair that has already grown out of the follicle does not change ...
If you had a smooth, easy transition to menopause, there's no need to apologize. You may not need any treatment, but menopause is still a good time to reflect on where you are in your life and how to ...
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
The other is to use the needle to remove liquid from the cochlea for the diagnosis of inner ear disorders, like Meniere’s disease, which causes dizzy spells, nausea, and hearing loss. By sampling the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results